Quantum-Si (NASDAQ:QSI) Director Acquires $460,000.00 in Stock

Quantum-Si Incorporated (NASDAQ:QSI) Director Charles Kummeth bought 500,000 shares of the firm’s stock in a transaction on Thursday, March 5th. The stock was purchased at an average price of $0.92 per share, for a total transaction of $460,000.00. Following the completion of the acquisition, the director directly owned 855,000 shares in the company, valued at $786,600. The trade was a 140.85% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Quantum-Si Price Performance

Quantum-Si stock opened at $1.05 on Thursday. The firm has a 50 day simple moving average of $1.09 and a 200-day simple moving average of $1.37. The stock has a market cap of $226.26 million, a price-to-earnings ratio of -2.02 and a beta of 3.00. Quantum-Si Incorporated has a 1-year low of $0.84 and a 1-year high of $3.10.

Quantum-Si (NASDAQ:QSI) last released its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.06. The firm had revenue of $0.45 million for the quarter, compared to analyst estimates of $0.76 million. Quantum-Si had a negative net margin of 4,160.06% and a negative return on equity of 43.90%. Equities analysts expect that Quantum-Si Incorporated will post -0.65 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quantum-Si in a research note on Monday, December 29th. Canaccord Genuity Group cut their price objective on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday, March 4th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $3.25.

Hedge Funds Weigh In On Quantum-Si

Hedge funds have recently made changes to their positions in the stock. Millennium Management LLC purchased a new stake in Quantum-Si in the first quarter valued at approximately $4,721,000. State Street Corp boosted its position in shares of Quantum-Si by 26.5% during the fourth quarter. State Street Corp now owns 3,562,721 shares of the company’s stock worth $3,919,000 after buying an additional 745,231 shares during the period. Squarepoint Ops LLC purchased a new position in shares of Quantum-Si during the third quarter worth $865,000. Geode Capital Management LLC grew its stake in shares of Quantum-Si by 15.1% in the second quarter. Geode Capital Management LLC now owns 3,447,738 shares of the company’s stock valued at $6,759,000 after buying an additional 452,850 shares in the last quarter. Finally, Bank of America Corp DE grew its stake in shares of Quantum-Si by 426.6% in the second quarter. Bank of America Corp DE now owns 465,999 shares of the company’s stock valued at $913,000 after buying an additional 377,504 shares in the last quarter. Hedge funds and other institutional investors own 39.90% of the company’s stock.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.